Cingulate (CING) Shares Skyrocket Over 150% on European ADHD Patent Announcement
    Cingulate (CING) Shares Skyrocket Over 150% on European ADHD Patent Announcement
    PRISM Biotech

    August 15, 2024  - by Ashlee Vogenthaler

    Cingulate (CING) Shares Skyrocket Over 150% on European ADHD Patent Announcement

    15 August 2024

    New York, August 15, 2024 - PRISM MarketView - PRISM Mental Health Index leader Cingulate (CING) saw shares rise over 150% on its recent news regarding the issuance of a European patent for its leading asset, CTx-1301 (dexmethylphenidate), designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The biopharmaceutical company leverages its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation pharmaceutical products.
    Cingulate Inc. - Prism MarketView

    Cingulate Inc. - Prism MarketView

    Cingulate® is a Phase 3 clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build

    Read More

    The patent, granted on August 14, 2024, as EP Patent No. 3261625, covers up to 30 European territories, including the United Kingdom. In addition to this European patent, Cingulate holds patents in Australia, Canada, and Israel, with pending applications in Hong Kong, the Republic of Korea, and the United States.

    “The approval of this patent is a significant milestone in our efforts to extend Cingulate’s impact beyond the United States and into the expanding ADHD markets in Europe and other regions. We anticipate securing additional patents soon as we continue to demonstrate the clinical success of CTx-1301 and progress toward filing a new drug application with the FDA.”

    Shane J. Schaffer, Cingulate’s Chairman and CEO

    To see this content properly accept cookies.
    About PRISM MarketView:
    Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on X.
    To see this content properly accept cookies.
    Disclaimer:
    PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
    Contact:
    PRISM MarketView
    info@prismmarketview.com
    646-863-6341
    Prism MarketView | Stock Market News & Investment Opportunities
    To see this content properly accept cookies.
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.